CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Looking to expand your small business? Discover various ways to explore new opportunities and drive growth effectively.
20,508 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
DTCC's decision to anchor tokenized securities on Stellar shifts the cross-border payments landscape. Ripple's ODL sh...
A 70-member roster of marketers across mortgage, real estate and housing tech is being honored for driving growth and...
A comprehensive IG review examines safety standards, platform tools, and regulatory reach as market conditions tilt t...
Hollywood, Florida leverages Live Local 4.0 to force a county decision on a Related Group beachfront project, signali...
Actors ratified a four-year pact with studios and streaming platforms, securing pay raises and safeguards on AI usage...
Chipmakers led a broad rebound as the S&P 500 climbed on June 8, 2026. The session showed tech rotation returning to ...
Super Micro Computer tumbled about 13% after proposing a $7 billion equity raise to back a $39 billion AI server back...
Governments are treating chipmaking as strategic. This article explains why intel's national security role matters fo...
Midwest cities are drawing new capital as Sun Belt rents retreat and new supply cools the boom. The belt boom over. m...
Oil has eased from double-digit spikes as tensions with Iran ease, nudging markets toward calmer inflation expectatio...
As AI demand reshapes silicon supply, the taiwan semi price prediction for 2026–2030 points to upside but with clear ...